Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: billkirn who wrote (6079)	5/15/1999 10:32:00 PM
From: Vector1	Read Replies (2) of 6136

Billkirn You are correct. The conversion price was determined based on the average price. Once the determination date was hit AGPH started trading in direct proportion to WLA's moves off the average price. However, I thought that the proxy was quite confusing and can see how folks got it wrong. I also want to thank the posters who made this thread one of the best on SI. In hindsight it looks like AGPH was an easy bet when it traded in the twenties 9 months ago. In reality it took guts as the shorts and some analysts argued that Sustiva was the end of Viracept. They were wrong. Thanks. V1

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next